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The present study tested the hypothesis that inadequate Zn intake might be responsible for failure to 
thrive and impaired catch-up growth in young rural Gambian children, and that Z n  supplements might 
be beneficial. Gambian children might be deprived of Zn because of its poor availability from their 
predominantly plant-based diet. Rural Gambian children (1 10; fifty boys, sixty girls) aged between 057 
and 2.30 years were divided into two matched groups, one to receive 70 mg Zn twice weekly for 1.25 
years, and the other a placebo. Growth and mid-upper-arm circumference were measured at  weekly 
intervals throughout the study and illnesses were monitored. Capillary blood and urine samples were 
collected a t  0, 2 and 8 weeks. Body weights and arm circumferences showed a linear increase, plus a 
seasonal effect (rainy season faltering). For body weight there was no significant overall effect of the 
supplement. For arm circumference, a very small (2%) but significant (P < 0.01) difference favoured the 
supplemented group. Plasma thymulin was much lower at  the first clinic than at  the second and third 
clinics, and in vitvo Zn stimulation was greater a t  the first clinic. There was, however, no effect of Zn 
in vivo. Likewise, Zn did not significantly benefit T-cell numbers or ratios, secretory IgA in urine, 
circulating hormone levels or biochemical indices of Zn status. One index of intestinal permeability, i.e. 
lactulose:creatinine, was improved (P < 0.02) by the supplement, but the lactulose: mannitol value was 
not; this requires further investigation. Dietary Zn deficiency is, thus, unlikely to be of major overall 
importance for rural Gambian children's ability to thrive, and blanket Zn supplementation is not 
justified. There may, however, be vulnerable sub-groups who would benefit from Zn supplements. 
Zinc: Infants: Supplementation: Growth: Thymulin 
Young Gambian children in rural farming communities grow, on average, at a rate 
consistent with international standards for the first 3 months of life while exclusively breast- 
fed, but during weaning, when the locally-available foods are of poor nutritional quality 
and are highly contaminated with pathogens, they fail to thrive, fail to catch up adequately 
after growth-faltering, and decline from international growth norms (Rowland et al. 1977). 
There are many reasons for this decline. One, which would be relatively easily and 
cheaply correctable if important, is dietary Zn deficiency. Zn availability may be poor in 
the diets of weanling infants of developing countries, since there is universal dependency on 
cereal staples but little animal protein or other easily utilized sources of Zn (Ferguson 
et al. 1989). A recent study of rural Gambian adolescents (Watkinson et al. 1985) showed 
that plasma Zn was below Western reference ranges. Unfortunately there are no reliable 
biochemical indices of marginal Zn status, particularly for young children; it is therefore, 
essential to use controlled supplementation, assessed by anthropometric indices (Walravens 
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Table 1. Characteristics of young rural Gambian children allocated to placebo and zinc- 
supplemented groups 
(Mean values with their standard errors) 
Unsupplemented group Zn-supplemented group 
n Mean SE Range n Mean SE Range 
Age (years) at outset 
Keneba* 
Manduar and Kanton Kundar* 
Percentage of males (all three villages) 
Mean body wt (kg) at outset 
Keneba 
Manduar and Kanton Kundar 
Keneba 
Manduar and Kanton Kundar 
Wt (YO of median for age)? 
20 1.65 
34 1.39 
46.3 
20 9.25 
34 9.00 
20 0.79 
34 0.82 
0058 1.22-2.04 19 1.68 0.053 1.30-2-06 
0-078 0.57-2.30 36 1.35 0.065 0'67-2.22 
43.6 
0.23 7'42-11.35 19 9.31 0.20 7'47-10'70 
0.25 6.25-1210 36 8.44 0.21 6.2611.02 
0.018 0.673-1.013 19 0.79 0.016 0,6884905 
0.019 0.601-1.154 36 0.78 0.017 0.600-1.060 
* For details, see p. 244; Keneba subjects were recruited from the age of 1.2 years, whereas those from 
t Expected weight-for-age based on the 50th centiles from Tanner et al. (1966). 
Manduar and Kanton Kundar were recruited from 0 5  years. 
et ul. 1989), tests of immune function (Fraker et al. 1986; Kruse-Jarres, 1989), and 
biochemical evidence. Recent studies of undernourished children in Jamaica have recorded 
dramatic improvements in growth indices, and evidence of changes in body composition, 
during convalescence (Golden & Golden, 1981 ; Golden, 1988). Studies in Bangladesh and 
India indicate that recovery from diarrhoea1 disease can benefit from Zn supplements 
(Sachdev et al. 1988; Simmer et al. 1988; Behrens et al. 1990; Roy et al. 1992). 
The purpose of the present study was to examine a variety of biochemical and functional 
indices in young rural Gambian children, during a controlled Zn supplementation trial, for 
15 months. 
SUBJECTS A N D  M E T H O D S  
Selection group allocation and supplementation protocol 
Subjects were enrolled from three villages in the West Kiang rural district of The Gambia, 
W. Africa: Keneba, Manduar and Kanton Kundar. Those in Manduar and Kanton 
Kundar included essentially all subjects aged between 0.57 and 2.3 years of age. In Keneba, 
all subjects below 1.2 years old were excluded because there, infants between 0.25 and 1.0 
years were receiving a food supplement. Although not deliberately fortified with Zn, this 
might affect their Zn status. Age-ranges and other characteristics at the outset are given in 
Table 1. None of the children was suffering from major long-term illnesses, and they were 
considered as representative of a generally healthy population of young rural Gambian 
children. 
Two matched groups, stratified by age and sex, were created by allocating subjects in 
successive age sequence from each sex into two groups. A double-blind protocol was used. 
The placebo group received a fruit-flavoured drink shown to contain negligible amounts of 
Zn. The supplemented group received the same drink with 70 mg added Zn, initially as zinc 
acetate, but subsequently as zinc gluconate (since compliance was better). The drinks were 
given twice weekly under supervision for 15 months : August 1989 - November 1990. 
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Just before the beginning of supplementation (clinic l), and again at 2 weeks (clinic 2) 
and 8 weeks (clinic 3), finger-prick capillary blood samples were collected for the 
measurement of T-lymphocyte subsets and biochemical indices. These time-intervals were 
chosen to examine the possibility that changes might occur either rapidly, or transiently, in 
response to the supplement. They were also chosen to test for changes during the rainy 
season (June-September), which is the time of maximum stress, infection, growth faltering 
(Rowland et al. 1977) and haematological decline. Zn-free heparin (Leo Laboratories, 
Princes Risborough, Bucks.) was used for anti-coagulation. Although blood samples were 
obtained from all the subjects, the amount obtained varied (median, 300 pl; approximate 
range, 5CL500 pl), and it was not possible to perform all the tests on all the subjects. Urine 
samples (6 h) were collected in U-bags (Downs' Surgical, Lansing, W. Sussex), with about 
0.5 ml chlorhexidine gluconate (200 g/l) as preservative. At the start of the second urine 
collection (8 weeks after the start) an oral dose of lactulose (0.2 g/kg body weight) and 
mannitol(O.05 g/kg body weight) was given, for the measurement of intestinal permeability 
(Northrop et at. 1990). Blood and urine samples were stored and transported at -25". Hair 
samples (1&30 mg) were collected from 42 o/o of the subjects at the end of the study. 
Anthropometry and illness records 
Body weights and mid-upper arm circumference (MUAC) were measured once weekly 
throughout the study ; body weights were measured with a portable electronic averaging 
balance (SECA, Todd Scales Ltd., Newmarket, Suffolk), the subjects being lightly clothed. 
The MUAC records for a 3-week period around week 40 had to be discarded because of 
an error in recording. Body lengths were measured only at the start and end of the study 
(mean of three independent measurements at each time), since this measurement caused 
some distress. Records of illness episodes were obtained from clinic attendance records. 
Immunological indices 
Numbers of CD4 and CD8 lymphocytes per ml blood and, hence, the CD4 : CD8 ratio were 
measured by the Dynabead immunomagnetic technique (Brinchmann et al. 1988); the 
antibody-linked magnetic beads being obtained from Dynal (UK) Ltd, Wirral, Merseyside. 
The isolated lymphocytes from 50 p1 blood were treated with Zapoglobin (Coulter 
Electronics, Luton, Beds.) to release their nuclei, which were stained with acridine orange 
dye and counted on a haemacytometer slide under a fluorescent microscope. Initially it was 
found that blood from Gambian infants behaved atypically by clumping irreversibly at 4" 
during the unavoidable interval of 1-2 d before counting. This tendency was subsequently 
overcome by frequent resuspension of the nuclei during storage. Because of the initial 
problems with resuspension, only the results at clinic 3 are shown. 
Urinary levels of secretory IgA (sIgA) were measured by a minor adaptation of a 
procedure developed for breast milk antimicrobial factors (Prentice et al. 1984, 1991). 
Complement component C3 was measured by an Ames Sera-Pak immuno C3, C4 Kit 
(Miles Ltd, Stoke Poges, Bucks.) requiring 5 pl plasma per assay. 
Biochemical indices 
Zn in plasma ( 5  pl) was measured by electrothermal atomic absorption spectroscopy (Shaw 
et al. 1982), and Zn in hair was measured by flame atomic absorption, after digestion for 
15 min at 40% power in a CEM (Buckingham, UK) MDS-81D microwave digestion 
system, using a pure HN0,-H,O mixture (85 : 15, v/v) for dissolution. Hair samples were 
obtained from the back of the head, with stainless-steel scissors, and were thoroughly 
washed with aqueous sodium lauryl sulphate (10 g/l), followed by absolute ethanol. 
246 C. J. B A T E S  A N D  OTHERS 
Plasma ferritin was measured by an ELISA assay requiring 22 p1 plasma (Anderson & 
Kelly, 1981). Haemoglobin was measured by Drabkins reagent, using 20 plcl blood. A Roche 
Centrifichem no. 1421 test kit based on the Jaffe reaction was used for creatinine analysis 
in unhydrolysed urine. For the hydroxyproline : creatinine ratio in urine samples, an 
amount of urine containing about 0.2 x mmol creatinine was hydrolysed overnight 
with ~ M - H C I ,  was adjusted to pH 6.0 with 6M-NaOl-I and was then assayed for 
hydroxyproline in a Roche Cobas Bio centrifugal analyser (Ho & Pang, 1989). 
Plasma thymulin was measured after freeze-drying and reconstitution of equal amounts 
of plasma from each of six subjects, 0.1 ml per pool, by an assay which tests the conversion 
of relatively azathioprine-resistant and antithyl-serum-resistant rosette-forming cells (RFC) 
obtained from adult thymectomized mice into thyl-positive RFC that are more sensitive to 
inhibition by azathioprine (Dardenne & Bach, 1975). The effect of Zn addition on thymulin 
activity in vitro was tested (Dardenne et al. 1982a; Prasad et al. 1988). Since the thymulin 
levels were very low at the outset, it was felt to be unnecessary to test the specificity of the 
thymulin peptide by a monoclonal antibody inactivation test (Dardenne et al. 1982b). 
Human growth hormone (HGH) was measured by a kit obtained from Diagnostic 
Products Corporation, Los Angeles, California (HGH double antibody), scaled down to 
use 10,d plasma per assay. Other blood assays included superoxide dismutase (EC 
1 .5.1.1) in erythrocyte haemolysates by the assay of Wheeler et al. (1 990) using the Cobas 
Bio analyser and requiring 0.8 pl packed cells, plasma alkaline phosphatase (EC 3.1 .3.1) 
by an assay adapted from Levine (1974) requiring 3 pl plasma, and plasma a,- 
antichymotrypsin and a,-acid glycoprotein by the method of Calvin & Price (1986), also on 
the Cobas Bio analyser and requiring 1-2 pl per assay. 
Ethical permission and informed consent 
The study was approved by the MRC Gambian Ethical Committee. The parents of the 
subjects were invited to give their consent, after the purpose and requirements of the study 
were explained to them, and they were free to withdraw their children at any time. 
Statistical treatment 
Cross-sectional comparisons between groups were made by Mann-Whitney U test or 
Student’s t test. Certain variables, i.e. thymulin, HGH, ferritin, lactulose: mannitol ratio, 
and lactulose : creatinine ratio, were transformed to natural logarithms before analysis. 
Because of the large number of tests performed, those differences which were significant at 
P = 0.01 -0.05 were designated ‘marginal’, and those below 0.01 as ‘significant’. 
For the longitudinal comparisons of weight and MUAC they were transformed to 
100. log, (weight) and 100. log, (MUAC) respectively, where the log transform takes care of 
the skew distributions and of the standard deviations increasing with time, while the factor 
of 100 expresses increments in log anthropometry in percentage units. Initially, separate 
mean values were obtained for each week of the study using a within-subject analysis which 
treats each subject as its own control, with week 1 being set arbitrarily to zero. This analysis 
was then extended to include a week x treatment group interaction to see how the pattern 
of growth differed in the two groups. 
The time trend was then summarized by a quadratic curve in weeks plus a superimposed 
sine wave. This latter curve was fitted as the sine and cosine of weeks scaled to a period of 
1 year, so as to optimize the phase shift. Interactions of the linear and quadratic weeks 
terms with treatment group were then fitted, to test for the significance of differences in 
growth pattern between the two groups. Further interaction terms were later fitted to test 
whether the observed differences in growth between the groups could be explained by 
underlying differences in village, sex or age. 
Z I N C  S U P P L E M E N T S  I N  I N F A N T S  247 
Table 2. Reasons for clinic visits by young rural Gambian children with or without zinc 
supplementation* 
- 
Unsupplemented group Zn-supplemented group Statistical significance 
of difference: 
No. of clinic visits? for: Mean Range Mean Range 22 ps  
Diarrhoea 1.22 0-5 1.51 0-8 0.25 0.80 
Malaria8 0 9 4  0-7 0.64 &4 1.68 0.09 
Respiratory illness 3.54 0.12 4.13 0-17 0.46 0.92 
‘Malnutrition’(/ 0.26 0 4  0.62 0-9 0.97 0.34 
All reasons combined 11.96 1-30 13.3 1 3-36 0.58 0.56 
* For details of subjects and treatments, see Table 1 and pp. 244245. 
t Expressed as the arithmetic mean of visits per subject. Data generally were positively skewed. 
1 Based on Mann-Whitney U test (two-tailed), for no. of visits per subject. 
8 Confirmed by microscopic examination. 
11 Generally either ‘underweight’ or ‘marasmus’. 
R E S U L T S  
Compliance. Of 112 subjects originally enrolled, two moved away from the village before 
the seventh week of the study (one from each supplement group); their data are omitted 
from the summaries and calculations. Six others (two from each of the three villages) 
moved away between 24 and 31 weeks of supplementation, and two others (one from 
Manduar, and one from Keneba) moved away at weeks 42 and 45. These eight subjects 
were equally distributed between the two supplement groups (four placebo, four 
supplemented) and their data are included. Likewise the data from the one child (Kanton 
Kanduar, placebo group) who died of malaria in the 54th week of study are retained. 
Illness records. Table 2 shows the mean number of clinic visits due to illness divided into 
several categories, for the two groups. By far the majority of the episodes occurred during 
the two rainy seasons (1989 and 1990). The number of diarrhoea1 episodes during the first 
half of the study was negatively correlated with weight gain during the same period (P < 
0.01) but was positively correlated with weight gain over the entire study (P < 0.05) and 
with MUAC gain over the entire study ( P  = 0.01). Of the five categories of illness shown 
in Table 2, only malaria episodes exhibited an inter-group difference which approached 
significance. If the episodes in the first month of the study were excluded, then the number 
of visits resulting in a positive malaria diagnosis was lower in the supplemented group with 
a significance (two-tailed) of Z 1.92, P = 0.054. 
Anthropometry. Fig. 1 (a )  shows the mean percentage change in body weight (all subjects) 
during the study. There clearly was a period of growth-faltering near the start (0-6 weeks), 
during late August - early October 1989, and again between 50 and 60 weeks, between early 
August and mid-October 1990. These correspond with rainy-season growth-faltering 
periods previously observed in other studies of this community. The growth patterns were 
best described mathematically as a linear increase with a superimposed sine-wave 
representing the seasonal fluctuation. 
Comparison of the weight gains in the two groups for each week of the study indicated 
that although there were more values above the zero line than below, indicating a 
favourable trend for the supplement, this did not achieve significance. There was no 
indication of any progressive beneficial effect of the supplement, indeed the greatest benefit 
occurred in the middle of the study, which corresponded to the middle of the dry season, 
February 1990. During the first period of weight-faltering at the beginning of the study, 
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Fig. 1. Percentage change in (a) body weight and (b) mid-upper-arm circumference (MUAC) at weekly intervals 
during the study for young rural Gambian children with (0) or without (-) zinc supplementation (for details, 
see Table 1). Each point is the mean value for all subjects in the study; 110 at the start; 102 by week 65. 
Weeks &9 were in the rainy season (July-September 1989); the dry season extended from approximately week 10 
to week 45, and the rainy season in 1990 extended from week 46 to week 62. 
three subjects in the unsupplemented group lost more than 0.1 kg/week over a 4-week 
period, whereas none of those in the supplemented group lost more than 0.1 kg/week over 
this period. During the second period of weight-faltering (weeks 52-58), four subjects in the 
unsupplemented group and six in the supplemented group lost more than 0.1 kg/week. 
Fig. l(b) shows the mean values for MUAC throughout the study. For this index the 
second period of growth-faltering was much more marked than for the weight changes; it 
continued from week 40 until the end of the study in November 1990. Nearly all the weekly 
values showed a positive effect of the supplement, and the overall difference was 
represented by a t value of 2.7 and P < 0.01 (109 do.  However, the Zn effect was small; 
only 2 % of the overall mean MUAC value (135 mm at the outset and 144 mm by the end 
of the study), and it did not increase progressively. The data in Table 3 confirm that there 
were no significant inter-group differences in the overall increases in body weight and 
MUAC between the start and the finish of the study. 
There was some indication that the male infants enjoyed a greater benefit from the 
supplement than the female infants, but there were no clear associations of benefit with 
particular villages or particular age-groups. Body length changes (Table 3) were very 
similar in both groups and showed no significant Zn effect. The same was true for each sex, 
village or age-group when analysed separately. 
Overall weight gain was strongly correlated with overall gain in MUAC (P < O.OOOl), 
and with overall height gain ( P  < 0.005), between subjects. 
Blood haemogiobin, lymphocyte counts and plasma complement (C3) levels 
Haemoglobin measurements were available for clinics 1 and 2 only (Table 4). Lymphocyte 
sub-set counts are recorded for clinic 3 only (Table 4). Plasma C3 complement was 
measured at all three clinics, but the data for clinic 1 were less complete than those for 
clinics 2 and 3 (Table 4). 
sIgA in urine is expressed in Table 4 as pg/6 h collection period, representing only the 
specific secretory material, free from plasma IgA or IgA fragments. For all four groups 
of urines, the tota1:secretory ratio was in the range 1.02-1.25, indicating very little 
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Table 3 .  Body length, weight and mid-upper-arm circumference (MUAC) for young rural 
Gambian children with or without zinc supplementation* 
(Mean values with their standard errors) 
Unsupplemented group Zn-supplemented group Statistical analysis 
of inter-group 
n Mean SE n Mean SE differences?: t 
Body length (mm): 
Aug 1989 
Nov 1990 
Change 
Body wt (kg): 
Aug 1989 
Nov 1990 
Change 
MUAC (mm): 
Aug 1989 
Nov 1990 
Change 
46 
46 
46 
50 
50 
50 
49 
49 
49 
777 
882 
105 
9.15 
11.63 
2.38 
137 
145 
7.7 
6.2 51 
6.2 51 
2.9 51 
0.18 53 
0.19 53 
0.13 53 
1.4 53 
1.3 53 
1.4 53 
758 
858 
100 
8.68 
11.07 
2.39 
133 
143 
8.7 
6.2 
6.2 
2.9 1.08 
0.16 
0.19 
0.10 0.06 
1.6 
1.5 
1 .o 0.58 
* For details of subjects and treatments, see Table 1 and pp. 244-245. 
t These comparisons have been limited to those subjects who yielded measurements a t  both the time points 
indicated. No significant differences attributable to the Zn supplement were detected. 
Table 4. Haemoglobin and immunity factors (lymphocyte counts, plasma C3 and urinary 
sIgA) for  young rural Gambian children with or without zinc supplementation* 
(Arithmetic mean values with their standard errors (SE) or geometric mean values with their SE and 95 % 
confidence intervals (CI)) 
Haemoglobin (g/l blood) 
Lymphocytes (/pl blood)? 
CD4 
CD8 
CD4: CD8 
C3 complement (mg/l plasma) 
Secretory IgA in urine @g/6 h)f 
Unsupplemented Zn-supplemented 
group group Statistical analysis 
Clinic of intergroup 
no n Mean SE or CI n Mean SE or CI differences§ t 
~- 
I 48 120 3 2  45 116 3 5  0 83 
2 55 116 2 0  50 117 3 3  0 26 
49 1047 73 52 956 69 1.03 
49 426 36 52 504 50 1.17 
49 2.72 0.17 52 2.47 0.26 0.73 
I 28 1490 87 29 1370 65 1.15 
2 48 1310 52 47 1430 58 1.53 
3 52 1540 63 52 1400 57 1.66 
I 19 38.0 24.5-58.9 25 24.8 15.8-39.0 0.90 
3 19 24.8 15.6-39.5 25 21.5 12.9-35.9 0.46 
- ~~ 
* For details of subjects dnd treatments, see Table I and pp 244-245 
t At clinic 3 only, insufficient plasma available to assay all the clinic 1 sample7 
8 Keneba and Kanton Kundar subjects only 
$ No significant inter-group differences attributable to the Zn supplement were detected, for any of these 
indices 
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supplemen tat ion * 
(Geometric means with 95 O/O confidence intervals (CI)) 
Unsupplemented group Zn-supplemented group 
Clinic Geometric Geometric 
no. n mean CI n mean CI 
Table 5 .  PIasma hormone levels,for young rural Gambian children with or without zinc 
- 
- 
Statistical analysis 
of inter-group 
differences§: t 
Thymulin (titre)? 1 5 4.6 3'5-6.0 5 4.0 4.M.O 
2 5 13.9 7G27.4 5 16.0 10.3-24.8 
3 5 42.2 35.9-50.4 5 36.8 21.8-61.6 
HGH (ng/ml)$ I 9 4.35 2.1-9.1 10 3.95 2.66.0 
2 14 7.54 5.0-11.2 22 4.78 2.9-7.7 
3 37 2.60 1.8-3.6 29 2.56 1.8-3.7 
1 .oo 
0.34 
0.45 
0.16 
0.84 
0.00 
* For details of subjects and treatments, see Table 1 and pp. 244246. 
7 Expressed as the highest dilutions of plasma for a borderline-detectable effect in the standard assay. Each 
$ Four zero values assigned a value of 0 1  ng/ml (detection limit). 
5 No significant inter-group differences attributable to the zinc supplement were detected. 
measurement was performed on a pool of ten samples of plasma of equal volumes. 
contamination with degradation products, or with plasma IgA. The sIgA output per unit 
creatinine showed a similar pattern. 
There was no indication of a Zn supplementation effect on any of these indices. 
Plasma hormone levels 
For the thymulin assay, pooled samples were used to obtain sufficient for each assay. As 
shown in Table 5, log plasma thymulin titres increased dramatically (by 2.5-fold in both 
groups), between clinic 1 and clinic 3. The increase was similar for both supplement groups. 
The ratio, titres with Zn added in vitro: those without, decreased between clinics 1 and 3 
from 3.64 to 1.25 in the unsupplemented group, and from 3.33 to 1.43 in the supplemented 
group. The overall changes between clinics were highly significant (P < O.Ol), but the 
differences between supplement groups (in vivo Zn effects) were not significant. 
For growth hormone (Table 5) only partial data-sets were obtained, and these do not 
indicate any effect of the Zn supplement. 
Plasma proteins and enzyme activities 
Data for superoxide dismutase activity in erythocytes were almost complete for clinics 1 
and 3 (Table 6); partial data-sets were available for plasma alkaline phosphatase and for 
plasma ferritin for all three clinics (Table 6). None of these indices exhibited a significant 
effect of the Zn supplement. There was a significant but transient increase in plasma al- 
antichymotrypsin (P < 0.01) and a,-acid glycoprotein (P < 0.02, not shown) in the 
supplemented group compared with the placebo group at clinic 2, but not at clinic 3. 
Urinary hydroxyproline : creatinine ratio, and intestinal permeability measured by urinary 
lactulose: mannitol ratios after oral sugar dosing 
The increase in urinary hydroxyproline : creatinine ratio (Table 7) between clinic 1 and 
clinic 3 was greater in the supplemented than in the placebo group, but not significantly so. 
There was a marginally significant effect of the supplement for the girls: for the 
unsupplemented groups the mean change was+0.037 (SE 0.022, n 21) mol/mol and for the 
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Table 6. Blood enzyme activities and ferritin levels for  young rural Gambian children with 
or without zinc supplementationt 
(Arithmetic means with their standard errors (SE) or geometric means with their SE and 95 YO 
confidence intervals (CI)) 
Unsupplemented Zn-supplemented Statistical 
group group analysis 
Clinic of inter-group 
no. n Mean SE or CI n Mean SE or CI differences: f 
Superoxide dismutase in 1 
erythrocytes (IU/mg haemoglobin) 3 
Alkaline phosphatase in plasma 1 
(IU/U 2 
3 
a,-Antichymotrypsin in plasma (g/l) 1 
Ferritin in plasma (,ug/l) 1 
2 
3 
2 
3 
52 
53 
31 
46 
44 
29 
41 
40 
9 
19 
45 
~ 
~ 
3.74 0.07 54 
3.25 0.09 53 
79.7 5.1 26 
75.6 4.5 46 
79.1 4.8 42 
0.78 0.058 28 
0.84 0.043 41 
089 0.041 41 
15.1 16-29.7 14 
30.7 21.544.3 22 
15.9 11.5-21'8 40 
3.60 
3.29 
74.7 
78.5 
67.5 
0.77 
1.02 
0.84 
18.2 
28.2 
17.2 
007  
0.08 
4.3 
4.1 
3.0 
0,045 
0.053 
0.048 
12.426.6 
2 1.1-37'0 
13.2-23.1 
0.60 
0.33 
0.75 
0.5 1 
1.48 
0.14 
2.65** 
0.79 
0.49 
0.40 
0.43 
The inter-group difference attributable to the Zn supplement was significant: (Student's t test) ** P < 001 
t For details of subjects and treatments, see Table 1 and pp. 244246. 
Table 7. Urinary indices of collagen turnover and of intestinal permeability for young 
rural Gambian children with or without zinc supplementation 
(Arithmetic means with their standard errors (SE) or geometric means with their SE and 95 'YO 
confidence intervals (CI)) 
Unsupplemented Zn-supplemented Statistical 
group group analysis 
Clinic of inter-group 
no n Mean SE or CI n Mean SE or CI differences: t 
Hydroxypro1ine:creatinine (molar ratio) 1 38 0.426 0.022 46 0.392 0.016 
3 39 0.461 0.022 45 0,463 0.023 
change 3-1 38 0.034 0.017 45 0.070 0.022 1.29 
Lactu1ose:creatinine (molar ratio) 3 39 056 0.46-0.68 43 0.35 0.254.48 2,52** 
Mannitol :creatinine (molar ratio) 3 39 1.25 0.132 44 1.01 0.097 1.48 
Lactulose : mannitol (molar ratio) 3 39 0.54 0.424.68 44 0.44 0.340.56 1.18 
The inter-group difference attributable to the Zn supplement was significant: ** P < 0.02. 
supplemented group it was+0.112 (SE 0.027, n 25); ( t  2.15, 43 df, P < 0.05). There was a 
significant positive correlation between the mean value of the hydroxyproline : creatinine 
ratio for each subject and the rate of body weight gain (P < 0.01) or length gain (P < 0.001) 
over the same period, but no correlation with MUAC gain. 
Intestinal permeability towards lactulose was significantly lower in the supplemented 
group (P < 0.02; Table 7). This supplement effect was observed consistently in all three 
study villages and both sexes. The results for absorption of mannitol and lactu- 
lose: mannitol ratio, however, were less clearcut. There was a large difference between the 
three study villages, and some evidence for a deleterious effect of the supplement (reduced 
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Table 8. Plasma and hair metal levels for  young rural Gambian children with or without 
zinc supplemen tat ion * 
(Mean values with their standard errors) 
Unsupplemented Zn-supplemented 
group group Statistical analysis 
of inter-group 
n Mean SE n Mean SE differences? : t 
Plasma Zn (pmol/l) Cfinic 2 28 15.2 1.6 30 15.2 1.8 0.00 
Clinic 3 44 16.3 1.3 46 17.8 1.3 0.82 
Hair Zn (pmol/g) End of study 22 2.60 0.18 22 2.45 022 0.54 
Hair Cu (pmol/g) End of study 20 0.28 0.021 22 0.26 0038 0.30 
* For details of subjects and treatments, see Table 1 and pp. 244245. 
t No significant inter-group differences attributable to the supplement were detected. 
absorption, P = 0.03) in Keneba. Neither mannitol nor the lactulose: mannitol ratio 
exhibited any significant supplement effect when all three villages were considered (Table 7). 
Thus, Zn appeared to reduce the leakage route taken by lactulose without affecting the 
normal brush-border absorption route for mannitol. The range of values in the present 
study was similar to that obtained in a previous study of Gambian children (Lunn et al. 
1991). 
Z n  concentrations in plasma and hair samples 
Plasma Zn measurements at clinics 2 and 3 and hair Zn and Cu measurements at the end 
of the study are shown in Table 8. These are incomplete data-sets because of limited 
availability of samples; in each case there was no significant effect of the Zn supplement. 
DISCUSSION 
Adequacy of Zn status in humans can only be determined by a range of functional tests 
before and during supplementation, since Zn concentrations at sites such as hair and 
plasma can be misleading (Aggett, 1990). Zn has many diverse roles in metabolic processes; 
the amounts at accessible sites may not reflect the supply at other more critically-susceptible 
ones. 
Evidence for Zn supplementation responses during the correction of Zn deficiency in 
humans has been reported for the following indices : (a) growth (including growth recovery 
during diarrhoea1 disease) (Golden & Golden, 1981 ; Hambidge, 1988; Sachdev et al. 1988; 
Simmer et al. 1988; Behrens et al. 1990; Prasad, 1991); (b) immune function, including cell- 
mediated and secretory immunoglobulin responses (Fraker et al. 1986; Prasad, 1991); 
(c) plasma thymulin (a Zn-containing hormone which controls cell-mediated immune 
function (Dardenne et al. 1982a: Prasad et al. 1988); (d) growth hormone levels and 
function (Ghavami-Maibodi et al. 1983); (e) alkaline phosphatase (Weisman & Hoyer, 
1985). Evidence for a decline in serum complement components during Zn deficiency has 
been reported (Kruse-Jarres, 1989), but is less well-established than the other effects of Zn. 
Erythrocyte superoxide dismutase appears to exhibit Cu dependence but not Zn dependence 
in animal studies (Bray & Bettger, 1990). 
In the present study the absence of a Zn supplementation effect on superoxide dismutase 
gives some reassurance that Cu status was not deleteriously affected by the Zn supplement. 
The same was true for hair Cu at the end of the study. Likewise, there were no changes in 
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indices of Fe status (plasma ferritin; blood haemoglobin) to suggest Zn competition for Fe 
absorption (Yardrick et af. 1989). 
There was a trend towards fewer malaria episodes in the Zn-supplemented group and, 
although not significant, this seems worthy of further investigation. Hydroxyproline 
excretion in the girls seemed to indicate a marginally-beneficial effect during the early stages 
of supplementation. MUAC appeared to benefit slightly in the boys. The picture for plasma 
thymulin levels was puzzling: at the start there were very low levels of active hormone, and 
a large in vitro response to Zn which disappeared as the dry season was entered. Other 
investigators (Prasad et af. 1988) have noted a significant decrease in serum thymulin 
activity during mild Zn deficiency in humans, but longitudinal studies of seasonal 
variations have not been performed. 
The improvement in lactulose : creatinine ratios in the Zn-supplemented group also 
requires further study. Although it may suggest a beneficial effect on mucosal integrity, the 
overall permeability index provided by the lactulose : mannitol ratio was not affected. The 
significant but transient increase in plasma a,-antichymotrypsin and a,-acid glycoprotein 
at clinic 2 may result from enhanced hepatic protein synthesis in the supplemented group, 
but it may equally represent an acute-phase reaction. 
The overall picture is one of reasonably adequate Zn status (confirmed by the relatively 
high plasma and hair Zn levels), and although some minor beneficial responses to the Zn 
supplement were observed, they were not entirely clearcut. One possibility, based on the 
observations and conclusions of Watkinson et af. (1985), Castillo-Duran et af. (1987), 
Golden (1988) and Aggett (1990), is that Zn may not be limiting if there is an inadequate 
supply of certain other nutrients. A transient benefit of Zn may, thus, represent a response 
which could only be sustained if other nutrients were also provided. Growth-faltering 
during the rainy season clearly cannot be prevented by Zn supplementation alone. 
The amount of Zn given, equivalent to 20 mg elemental Zn/d, was five times greater than 
the estimated average requirement of UK children between 7 months and 3 years old 
(Department of Health, 1991), and should, therefore, correct a simple dietary deficiency, 
despite the existence of dietary components which limit Zn bioavailability (Department of 
Health, 1991) or of losses during bouts of diarrhoea1 disease. 
Zn status in Gambians may be better than is predicted from their plant-based diet. A 
recent study of breast-milk Zn from lactating Gambians, for example, found higher levels 
than in breast milk from UK mothers at equivalent stages of lactation (Bates & Tsuchiya, 
1990). 
From the practical viewpoint, most young Gambian children would gain little from Zn 
supplements alone. A sub-group which may be at increased risk of functional Zn deficiency 
are sufferers from chronic diarrhoea (McClain et af. 1985; Gatheru et af. 1988; Sachdev 
et af. 1988; Behrens et al. 1990; Roy et af. 1992). Selection procedures are needed to identify 
potentially-responsive individuals, and future experimental designs should explore the 
effects of Zn supplements combined with other nutrients, in high-risk populations. 
The authors wish to thank the subjects and their parents for their patient co-operation and 
Mr E. Jarjou and Mr B. Kanteh for their technical assistance. 
REFERENCES 
Aggett, P. J. (1990). Malnutrition and trace element metabolism. In The Malnourished Child. NestlP Nurrition 
Workshop Series no. 18, pp. 155-176 [R. M. Suskind and L. Lewinter-Suskind, editors]. New York: 
VeveyIRaven Press Ltd. 
Anderson, M. G. & Kelly, A. M. (1981). Serum ferritin by a rapid and inexpensive ELISA method. Clinica 
Chimica Acta 116, 405408. 
9-2 
254 C. J. B A T E S  AND OTHERS 
Bates, C. J. & Tsuchiya, H. (1990). Zinc in breast milk during prolonged lactation: comparison between the UK 
and The Gambia. European Journal of Clinical Nutrition 44, 61-69. 
Behrens, R. H., Tomkins, A. M. & Roy, S. K. (1990). Zinc supplementation during diarrhoea, a fortification 
during malnutrition? Lancet ii, 442443. 
Bray, T. M. & Bettger, W. J. (1990). The physiological role of zinc as an antioxidant. Free Radicals in Biology and 
Medicine 8, 28 1-291. 
Brinchmann, J. E., Vartdal, F., Gaudernack, G., Markussen, G., Funderud, S., Ugelstad, J. &Thorsby, E. (1988). 
Direct immunomagnetic quantification of lymphocyte subsets in blood. Clinical and Experimental Immunology 
71, 182-186. 
Calvin, J .  & Price, C. P. (1986). Measurement of serum a,-antichymotrypsin by immunoturbidimetry. Annals of 
Clinical Biochemistry 23, 206209. 
Castillo-Duran, C., Heresi, G., Fisberg, M. & Uauy, R. (1987). Controlled trial of zinc supplementation during 
recovery from malnutrition : effects on growth and immune function. American Journal of Clinical Nutrition 45, 
602-608. 
Dardenne, M. & Bach, J. F. (1975). The sheep cell rosette assay for the evaluation of thymic hormones. In 
Biological Activity of Thymic Hormones, pp. 235-243 [D. Van Bekkum, editor]. Rotterdam : Kooyer Scientific 
Publications. 
Dardenne, M., Pleau, J. M. & Nabarra, P. (1982~). Contribution of zinc and other metals to the biological activity 
of the serum thymic factor. Proceedings of the National Academy of Sciences, USA 79, 537C5373. 
Dardenne, M., Pleau, J. M. & Savino, W. (1982b). Monoclonal antibody against the serum thymic factor (FTS). 
Immunology Letters 48, 61-64. 
Department of Health (1991). Dietary Reference Values for Food Energy and Nutrients for the United Kingdom. 
Report of the Panel on Dietary Reference Values of the Committee on Medical Aspects of Food Policy. London: 
H.M. Stationery Office. 
Ferguson, E. L., Gibson, R. S., Thompson, L. U .  & Ounpuu, S. (1989). Dietary calcium, phytate and zinc intakes 
and the calcium, phytate and zinc molar ratios of the diets of a selected group of East African children. 
American Journal of Clinical Nutrition 50, 145&1456. 
Fraker, P. J., Gershwin, M. E., Good, R. A. & Prasad, A. S. (1986). Interrelationship between zinc and immune 
function. Federation Proceedings 45, 14741479. 
Gatheru, Z., Kinoti, S., Alwar, J.  & Mwita, M. (1988). Serum zinc levels in children with kwashiorkor aged one 
to three years at Kenyatta National Hospital and the effect of zinc supplementation during recovery. East 
African Medical Journal 65, 67CL679. 
Ghavami-Maibodi, S.  Z., Collipp, P. J., Castro-Magana, M. C., Stewart, C. & Chen, Y. (1983). Effect of oral zinc 
supplements on growth, hormonal levels and zinc in healthy short children. Annals of Nutrition and Metabolism 
27, 214219. 
Golden, B. E. (1988). Zinc in cell division and tissue growth: physiological aspects. In Zinc in Human Biology, 
pp. 119-128 [C. F. Mills, editor]. Berlin: Springer-Verlag. 
Golden, M. H. N. & Golden, B. E. (1981). Effect of zinc supplementation on the dietary intake, rate of weight 
gain, and energy cost of tissue disposition in children recovering from severe malnutrition. American Journal 
of Clinical Nutrition 34, 906908. 
Hambidge, K. M. (1988). Mild zinc deficiency in human subjects. In Zinc in Human Biology, pp. 281-296 [C. F. 
Mills, editor]. Berlin : Springer-Verlag. 
Ho, K.-C. & Pang, C. P. (1989). Automated analysis of urinary hydroxyproline. Clinica Chimica Acta 185, 
191-196. 
Kruse-Jarres, J. D. (1989). The significance of zinc for humoral and cellular immunity. Journal of Trace Elements 
and Electrolytes in Health and Disease 3, 1-8. 
Levine, J. B. (1974). Determination in blood with automated analyzers. In Methods of Enzymatic Analysis, 2nd 
ed., vol. 2. pp. 856870 [H. U. Bergmeyer, editor]. New York: Academic Press. 
Lunn, P. G., Northrop-Clewes, C. A. & Downes, R. M. (1991). Recent developments in the nutritional 
management of diarrhoea. 2. Chronic diarrhoea and malnutrition in The Gambia: studies on intestinal 
permeability. Transactions of the Royal Society of Tropical Medicine & Hygiene 85, 8-1 I .  
McClain, C. J., Kasarskis, E. J. &Allen, J. J. (1985). Functional consequences of zinc deficiency. Progress in Food 
and Nutrition Science 9, 185-226. 
Northrop, C. A,, Lunn, P. G. & Behrens, R. H. (1990). Automated enzymatic assays for the determination of 
intestinal permeability probes in urine. I .  Lactulose and lactose. Clinica Chimica Acta 187, 79-88. 
Prasad, A. S. (1991). Discovery of human zinc deficiency and studies in an experimental human model. American 
Journal of Clinical Nutrition 53, 403412. 
Prasad, A. S., Meftah, S. & Abdallah, J. (1988). Serum thymulin in human zinc deficiency. Journal of Clinical 
Investigation 82, 1202-1210. 
Prentice, A,, Prentice, A. M., Cole, T. J., Paul, A. A. & Whitehead, R. G. (1984). Breast-milk antimicrobial 
factors of rural Gambian mothers. 1. Influence of stage of lactation and maternal plane of nutrition. Acta 
Paediatrica Scandinavica 73, 796-802. 
Prentice, A,, Stirling, D. M., Sullivan, P. B., Northrop-Clewes, C. A. & Lunn, P. G. (1991). Raised urinary 
secretory IgA in chronic diarrhoea. Archives of Disease in Childhood 66, 223-226. 
Z I N C  SUPPLEMENTS I N  I N F A N T S  255 
Rowland, M. G.  M., Cole, T. J. & Whitehead, R. G.  (1977). A quantitative study into the role of infection in 
determining nutritional status in Gambian village children. British Journal of Nutrition 37, 441450. 
Roy, S. K., Behrens, R. H., Haider, R., Akramuzzaman, S. M., Mahalanabis, D., Wahed, M. A. & Tomkins, 
A. M. (1992). Impact of zinc supplementation on intestinal permeability in Bangladeshi children with acute 
diarrhoea and persistent diarrhoea syndrome. Journal of Pediatric Gastroenterology and Nutrition 15, 289-296. 
Sachdev, H. P. S., Mittal, N. K., Mittal, S. K. & Yadav, H. S. (1988). A controlled trial on utility of oral zinc 
supplementation on acute dehydrating diarrhea in infants. Journal of Pediatric Gastroenterology and Nutrition 
Shaw, J .  C .  L., Bury, A. J., Barber, A., Mann, L. &Taylor, A. (1982). A micromethod for the analysis of zinc in 
plasma or serum by atomic absorption spectrophotometry using graphite furnace. Clinica Chimica Acta 118, 
Simmer, K.. Khanum, S., Carlsson, L. & Thompson, R. P. H. (1988). Nutritional rehabilitation in Bangladesh 
- the importance of zinc. American Journal of Clinical Nutrition 41, 10361040. 
Tanner, J. M., Whitehouse, R. H. & Takaishi, M. (1966). Standards from birth to maturity for height, weight, 
height velocity and weight velocity: British children, 1965, part 11. Archives ofDisease in Childhood41,613-635. 
Walravens, P. A,, Hambidge, K. M. & Koepfer, D. M. (1989). Zinc supplementation in infants with a nutritional 
pattern of failure to thrive: a double-blind controlled study. Pediatrics 83, 532-538. 
Watkinson, M., Aggett, P. J. & Cole, T. J. (1985). Zinc and acute tropical ulcers in Gambian children and 
adolescents. American Journal of Clinical Nutrition 41, 43-51. 
Weismann, K. & Hoyer, H. (1985). Serum alkaline phosphatase and serum zinc levels in the diagnosis and 
exclusion of zinc deficiency in man. American Journal of Clinical Nutrition 41, 12141219. 
Wheeler, C. R., Salzman, J. A., El-Sayed, N. M., Omaye, S. T. & Korte D. W. (1990). Automated assays for 
superoxide dismutase, catalase, glutathione peroxidase and glutathione reductase activity. Analytical 
Biochemistry 184, 193-199. 
Yardrick, M. K., Kenney, M. A. & Winterfeldt, E. A. (1989). Iron, copper and zinc status: response to 
supplementation with zinc and iron in adult females. American Journal of Clinical Nutrition 49, 145-150. 
7, 877-881. 
229-239. 
Printed in Great Britain 
